Study Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes March 1, 2022
News Journey Biosciences appoints Greg Dooley & Gordie Nye to its board of directors October 28, 2021
News Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care October 14, 2021
News Introducing Journey Biosciences and NaviDKD: Preventing Diabetes-Related Kidney Complications September 30, 2021
Study Advanced Glycation End Products (AGEs); Role in Development and Progression of Kidney Disease in Type 1 Diabetes in DCCT/EDIC July 1, 2018
